Award recordCONTRACT

TRAVERE THERAPEUTICS, INC.

PIID 36C24526N0794· VHA· 245-NETWORK CONTRACT OFFICE 5 (36C245)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $15,867 net obligations· UEI JUBZMHK84S36· CA

Description

PATIENT MEDICATION ORDER OF FILSPARI 400MG - WASHINGTON DC VA MEDICAL CENTER PHARMACY ORDER.

First action · last action
2026-08-05 · 2026-08-05
Transactions
1
First transaction's obligation
$15,867
Base + all options value (sum of deltas)
$15,867
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0239
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$15,867$0Base award · 2026-08-05 · this action $15,867 · running total $15,867
  • Base2026-08-05+$15,867= $15,867
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-08-05+$15,867$15,867PATIENT MEDICATION ORDER OF FILSPARI 400MG - WASHINGTON DC VA MEDICAL CENTER PHARMACY ORDER.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JUBZMHK84S36)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0779245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,372FY2026
36C24526N0725245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,867FY2026
36C24526N0675245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,867FY2026
36C24526N0571245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,372FY2026
36C24526N0554245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,667FY2026
36C26226N0373262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$131,523FY2026

Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24526N0840TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$19,139FY2026
36C24526N0839TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$38,360FY2026
36C24526N0837QOL MEDICAL LLC245-NETWORK CONTRACT OFFICE 5 (36C245)$16,945FY2026
36C24526N0834GALDERMA LABORATORIES, L.P.245-NETWORK CONTRACT OFFICE 5 (36C245)$16,960FY2026
36C24526N0835TAKEDA PHARMACEUTICALS AMERICA, INC.245-NETWORK CONTRACT OFFICE 5 (36C245)$34,605FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24526N0794_3600_36F79721D0239_3600 · retrieved 2026-09-26.